| RS2507910150 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507916875 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507916894 |
PIEZO1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2507917110 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507917117 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS2507917271 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507919052 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507921984 |
DLG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507922013 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507926129 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507926253 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507926524 |
PIEZO1
|
Health Risk |
Likely pathogenic |
PIEZO1-related disorder, PIEZO1-related disorder |
| RS2507928869 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2507929172 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507929748 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507932362 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507933264 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2507933267 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507933288 |
CTC1
|
Health Risk |
Likely pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 1, Cerebroretinal microangiopathy with calcifications and cysts 1 |
| RS2507933457 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2507934482 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2507935242 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2507935881 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS2507936447 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2507937769 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2507940250 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507940350 |
TEKT3
|
Health Risk |
Pathogenic |
Spermatogenic failure 81, Spermatogenic failure 81 |
| RS2507940839 |
DLG4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2507942569 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507942610 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507944348 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS2507944638 |
FOXC2
|
Health Risk |
Likely pathogenic |
— |
| RS2507944810 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS2507945223 |
FOXC2
|
Health Risk |
Likely pathogenic |
FOXC2-related disorder, FOXC2-related disorder |
| RS2507945608 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS2507945700 |
FOXC2
|
Health Risk |
Pathogenic |
FOXC2-related disorder, FOXC2-related disorder |
| RS2507945808 |
FOXC2
|
Health Risk |
Likely pathogenic |
FOXC2-related disorder, FOXC2-related disorder |
| RS2507945813 |
FOXC2
|
Health Risk |
Likely pathogenic |
FOXC2-related disorder, FOXC2-related disorder |
| RS2507946000 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507946061 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507946080 |
FOXC2
|
Health Risk |
Likely pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS2507946309 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Inborn genetic diseases |
| RS2507946358 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507947636 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2507947953 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507948437 |
CTC1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2507959298 |
PARN
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2507960503 |
PARN
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS2507962377 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2508005637 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2508006285 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2508007696 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2508013671 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508015311 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508020967 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508023271 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508024645 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS2508028388 |
DLG4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2508034309 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508038550 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508077437 |
PMP22
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease type 1E |
| RS2508077781 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2508077811 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS2508078064 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS2508083151 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2508108160 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508108364 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508108464 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508108674 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508109031 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508109484 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508112587 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2508124364 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508124531 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508124592 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508125103 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508125114 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2508125315 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508125390 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508125407 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508125537 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508125654 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508125672 |
NF1
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Juvenile myelomonocytic leukemia |
| RS2508125881 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508126300 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2508126744 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2508130127 |
KIF1C
|
Health Risk |
Likely pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2508135079 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2508136381 |
POLR2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2508137778 |
TAOK1
|
Health Risk |
Pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2508139347 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2508140575 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, familial spinal |
| RS2508140646 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508140663 |
NF1
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Juvenile myelomonocytic leukemia |
| RS2508140688 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508140716 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508140860 |
NF1
|
Health Risk |
Pathogenic |
NF1-related disorder, NF1-related disorder |
| RS2508140872 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2508141132 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508141172 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |